Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q1 2022 · 10-Q
Revenue$257.72M$257.72M+26.2% vs Q1 2021 Net Income$69.62M$69.62M+108.5% vs Q1 2021 EPS Diluted$1.69$1.69+103.6% vs Q1 2021 Gross Profit$170,997,000+24.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flow$48,434,000−26.6% Free Cash Flowderived$42,364,000−23.1% Margins · derivedGross margin66.4%−1.1 pt vs Q1 2021
Operating margin24.5%+0.5 pt vs Q1 2021
Net margin27.0%+10.7 pt vs Q1 2021
ended Sep 30, 2021 · filed Nov 8, 2021 · 39 d after period end